Resorcinol

Resorcinol

SCHEMBL17818516

N#Cc1ccccc1C#N.N#Cc1ccccc1C#N.Oc1cccc(O)c1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.57
CA2 P00918 3/20 0.57
ALDH1A1 P00352 3/20 0.57
CA12 O43570 2/20 0.57
CA9 Q16790 2/20 0.57
CA14 Q9ULX7 2/20 0.57
LMNA P02545 1/20 0.57
CA5A P35218 1/20 0.57
HSD17B10 Q99714 1/20 0.57
CA5B Q9Y2D0 1/20 0.57
ESR2 Q92731 2/20 0.50
AR P10275 1/20 0.47
TSHR P16473 3/20 0.44
SYK P43405 1/20 0.42
ESR1 P03372 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
CA1 P00915 2/20 0.41
CYP2C9 P11712 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resorcinol SCHEMBL15137008 1.00 CYP3A4 (0.57) CYP3A4CA2ALDH1A1CA12CA9
Metacresol SCHEMBL20511145 0.86 ACHE (0.65) CYP3A4CA2ALDH1A1CA12CA9
Phenol SCHEMBL28712610 0.85 ESR2 (0.59) CA2ALDH1A1CA12CA9CA14
Phenol SCHEMBL21995529 0.85 ESR2 (0.59) CA2ALDH1A1CA12CA9CA14
Phenol SCHEMBL28984274 0.85 ESR2 (0.59) CA2ALDH1A1CA12CA9CA14
Resorcinol SCHEMBL19410619 0.85 ALDH1A1 (0.41) CYP3A4CA2ALDH1A1CA12CA9
Resorcinol SCHEMBL28244156 0.82 ALDH1A1 (0.75) CYP3A4CA2ALDH1A1CA12CA9
SCHEMBL1028218 0.80 ESR2 (0.65) CYP3A4ESR2ARADORA2AADORA2B
Resorcinol SCHEMBL11651641 0.79 ALDH1A1 (0.71) CYP3A4CA2ALDH1A1CA12CA9
Resorcinol SCHEMBL1155783 0.79 ALDH1A1 (0.71) CYP3A4CA2ALDH1A1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110461814-B Resin blends, prepregs and articles containing a phthalonitrile reactive diluent and a bisphthalonitrile resin 3M创新有限公司 2023-04-14 CN claimed
US-11292891-B2 Resin blends containing a phthalonitrile reactive diluent and a diphthalonitrile resin, prepregs, and articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-04-05 US claimed
EP-3887428-B1 RESIN BLENDS INCLUDING PHTHALONITRILE RESIN AND THIADIAZOLE SUBSTITUTED PHTHALONITRILE COMPOUND, ARTICLES, COMPOUNDS, AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-05-27 EP disclosed
US-12291602-B2 Polymerizable compositions including a phthalonitrile resin and a polyoxometalate, articles, and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-05-06 US disclosed
EP-3390539-B1 BENZOXAZINE AND PHTHALONITRILE RESIN BLENDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-12-04 EP disclosed
EP-3436428-B1 BISPHENOL M DIPHTHALONITRILE ETHER RESIN, BISPHENOL P DIPHTHALONITRILE ETHER RESIN, METHODS OF MAKING SAME, RESIN BLENDS, AND TWO COMPONENT SYSTEMS 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-07-10 EP disclosed
EP-4107217-B1 POLYMERIZABLE COMPOSITIONS INCLUDING A PHTHALONITRILE RESIN AND A POLYOXOMETALATE, ARTICLES, AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-03-27 EP disclosed
US-11932750-B2 Resin blends including phthalonitrile resin and thiadiazole substituted phthalonitrile compound, articles, compounds, and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-03-19 US disclosed
CN-110461814-B Resin blends, prepregs and articles containing a phthalonitrile reactive diluent and a bisphthalonitrile resin 3M创新有限公司 2023-04-14 CN disclosed
US-20230063744-A1 Polymerizable Compositions Including a Phthalonitrile Resin and a Polyoxometalate, Articles, and Methods 3M INNOVATIVE PROPERTIES COMPANY 2023-03-02 US disclosed
EP-4107217-A1 POLYMERIZABLE COMPOSITIONS INCLUDING A PHTHALONITRILE RESIN AND A POLYOXOMETALATE, ARTICLES, AND METHODS 3M Innovative Properties Company (US) 2022-12-28 EP disclosed
US-9815235-B2 Controlling crosslinking density and processing parameters of phthalonitriles THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2017-11-14 US disclosed
WO-2017172515-A1 BISPHENOL M DIPHTHALONITRILE ETHER RESIN, BISPHENOL P DIPHTHALONITRILE ETHER RESIN, METHODS OF MAKING SAME, RESIN BLENDS, AND TWO COMPONENT SYSTEMS 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-10-05 WO disclosed
WO-2017173040-A1 RESIN BLENDS OF RESORCINOL DIPHTHALONITRILE ETHER WITH BISPHENOL M DIPHTHALONITRILE ETHER AND/OR BISPHENOL T DIPHTHALONITRILE ETHER 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-10-05 WO disclosed
WO-2017105890-A1 BENZOXAZINE AND PHTHALONITRILE RESIN BLENDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-06-22 WO disclosed
US-20170001357-A1 CONTROLLING CROSSLINKING DENSITY AND PROCESSING PARAMETERS OF PHTHALONITRILES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2017-01-05 US disclosed
US-20170002146-A1 CONTROLLING CROSSLINKING DENSITY AND PROCESSING PARAMETERS OF PHTHALONITRILES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2017-01-05 US disclosed
US-9464170-B2 Controlling crosslinking density and processing parameters of phthalonitriles THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2016-10-11 US disclosed
WO-2016099667-A1 CONTROLLING CROSSLINKING DENSITY AND PROCESSING PARAMETERS OF PHTHALONITRILES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2016-06-23 WO disclosed
US-20160168327-A1 CONTROLLING CROSSLINKING DENSITY AND PROCESSING PARAMETERS OF PHTHALONITRILES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11292891-B2 Resin blends containing a phthalonitrile reactive diluent and a diphthalonitrile resin, prepregs, and articles PNN, RPN1, DCXR CYP3A4 623/4885CA2 4757/4885ALDH1A1 720/4885
US-11932750-B2 Resin blends including phthalonitrile resin and thiadiazole substituted phthalonitrile compound, articles, compounds, and methods THUMPD1, RBBP5, RB1 CYP3A4 1224/4885CA2 4764/4885ALDH1A1 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.